115 related articles for article (PubMed ID: 2986153)
41. Effect of V1/V2-receptor antagonism on renal function and response to vasopressin in conscious dogs.
Rose CE; Rose KY; Kinter LB
Am J Physiol; 1991 Feb; 260(2 Pt 2):F273-82. PubMed ID: 1825453
[TBL] [Abstract][Full Text] [Related]
42. Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: comparison with the renin-angiotensin system and the sympathetic nervous system.
Creager MA; Faxon DP; Cutler SS; Kohlmann O; Ryan TJ; Gavras H
J Am Coll Cardiol; 1986 Apr; 7(4):758-65. PubMed ID: 3514728
[TBL] [Abstract][Full Text] [Related]
43. Coronary vasoconstriction produced by vasopressin in anesthetized goats. Role of vasopressin V1 and V2 receptors and nitric oxide.
Fernández N; García JL; García-Villalón AL; Monge L; Gómez B; Diéguez G
Eur J Pharmacol; 1998 Jan; 342(2-3):225-33. PubMed ID: 9548390
[TBL] [Abstract][Full Text] [Related]
44. Contribution of vasopressin and the sympathetic nervous system in the early phase of high sodium one-kidney renal hypertension.
Hinojosa C; Haywood JR
Hypertension; 1984; 6(6 Pt 1):848-54. PubMed ID: 6240442
[TBL] [Abstract][Full Text] [Related]
45. AVP-induced pulmonary vasodilation during specific V1 receptor block in conscious dogs.
Nyhan DP; Clougherty PW; Murray PA
Am J Physiol; 1987 Sep; 253(3 Pt 2):H493-9. PubMed ID: 2888317
[TBL] [Abstract][Full Text] [Related]
46. Development of high sodium renal hypertension during chronic blockade of the vascular effects of vasopressin.
Hinojosa C; Haywood JR
J Pharmacol Exp Ther; 1986 Aug; 238(2):492-6. PubMed ID: 2874211
[TBL] [Abstract][Full Text] [Related]
47. Vasopressin antagonists block peripheral as well as central vasopressin receptors.
De Wied D; Gaffori O; Van Ree JM; De Jong W
Pharmacol Biochem Behav; 1984 Sep; 21(3):393-400. PubMed ID: 6093152
[TBL] [Abstract][Full Text] [Related]
48. Does vasopressin sustain blood pressure in conscious spontaneously hypertensive rats?
Filep J; Fejes-Tóth G
Hypertension; 1986 Jun; 8(6):514-9. PubMed ID: 2872162
[TBL] [Abstract][Full Text] [Related]
49. Physiological regulation of the renal vasopressin receptor-effector pathway in dogs.
Kinter LB; Caldwell N; Caltabiano S; Winslow C; Brooks DP; Huffman WF
Am J Physiol; 1990 Mar; 258(3 Pt 2):R763-9. PubMed ID: 2138428
[TBL] [Abstract][Full Text] [Related]
50. Temporal differences between the involvement of angiotensin II and endothelin in the cardiovascular responses to endotoxaemia in conscious rats.
Gardiner SM; Kemp PA; March JE; Bennett T
Br J Pharmacol; 1996 Dec; 119(8):1619-27. PubMed ID: 8982510
[TBL] [Abstract][Full Text] [Related]
51. Short-term hemodynamic effects of vasopressin V1-receptor inhibition in chronic right-sided congestive heart failure.
Stone CK; Liang CS; Imai N; Sakamoto S; Sladek CD; Hood WB
Circulation; 1988 Nov; 78(5 Pt 1):1251-9. PubMed ID: 3180381
[TBL] [Abstract][Full Text] [Related]
52. Role of angiotensin and vasopressin on blood pressure of ganglionic blocked dogs.
Houck PC; Fiksen-Olsen MJ; Britton SL; Romero JC
Am J Physiol; 1983 Jan; 244(1):H115-20. PubMed ID: 6129807
[TBL] [Abstract][Full Text] [Related]
53. Heterogeneous renal responses to atrial natriuretic factor. I. Chronic caval dogs.
Maher E; Cernacek P; Levy M
Am J Physiol; 1989 Nov; 257(5 Pt 2):R1057-67. PubMed ID: 2531552
[TBL] [Abstract][Full Text] [Related]
54. Neurohumoral regulation of the pulmonary circulation during circulatory hypotension in conscious dogs.
Peterson WP; Trempy GA; Nishiwaki K; Nyhan DP; Murray PA
J Appl Physiol (1985); 1993 Oct; 75(4):1675-82. PubMed ID: 7904266
[TBL] [Abstract][Full Text] [Related]
55. Arterial baroreceptors control plasma vasopressin responses to graded hypotension in conscious dogs.
Thrasher TN; Chen HG; Keil LC
Am J Physiol Regul Integr Comp Physiol; 2000 Feb; 278(2):R469-75. PubMed ID: 10666149
[TBL] [Abstract][Full Text] [Related]
56. Role of vasopressin in blood pressure regulation during adrenal insufficiency.
Schwartz J; Keil LC; Maselli J; Reid IA
Endocrinology; 1983 Jan; 112(1):234-8. PubMed ID: 6847819
[TBL] [Abstract][Full Text] [Related]
57. Cardiovascular response to vasopressin vasopressor antagonist administration during water deprivation in the rat.
Rockhold RW; Share L; Crofton JT; Brooks DP
Neuroendocrinology; 1984 Feb; 38(2):139-44. PubMed ID: 6546972
[TBL] [Abstract][Full Text] [Related]
58. Renin and vasopressin responses to graded reductions in atrial pressure in conscious dogs.
O'Donnell CP; Thompson CJ; Keil LC; Thrasher TN
Am J Physiol; 1994 Mar; 266(3 Pt 2):R714-21. PubMed ID: 8160864
[TBL] [Abstract][Full Text] [Related]
59. Peripheral mechanisms involved in the pressor and bradycardic effects of centrally administered arachidonic acid.
Aydin C; Yalcin M
Prostaglandins Leukot Essent Fatty Acids; 2008 Jun; 78(6):361-8. PubMed ID: 18571395
[TBL] [Abstract][Full Text] [Related]
60. Coronary arteriolar vasoconstriction in myocardial ischaemia. Vasopressin, renin-angiotensin system and ANF.
Ertl G; Bauer B
Eur Heart J; 1990 Apr; 11 Suppl B():53-7. PubMed ID: 2142082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
